SCHEMBL185457

SCHEMBL185457

CCN(c1ccccc1)c1ccc(CNC(=O)C2(NC(=O)Oc3cncnc3)CC2)cc1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
BDKRB1 P46663 3/20 0.49
FAAH O00519 8/20 0.38
TRPV1 Q8NER1 5/20 0.37
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CTSL P07711 1/20 0.36
CTSB P07858 1/20 0.36
CTSS P25774 1/20 0.36
OPRM1 P35372 1/20 0.35
OPRD1 P41143 1/20 0.35
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
EPHX1 P07099 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL187120 0.90 BDKRB1 (0.50) BDKRB1FAAHTRPV1NPC1RAB9A
SCHEMBL2810317 0.87 BDKRB1 (0.60) BDKRB1CTSLCTSBCTSSOPRM1
SCHEMBL184989 0.83 BDKRB1 (0.50) BDKRB1FAAHTRPV1
SCHEMBL185880 0.82 BDKRB1 (0.47) BDKRB1FAAHTRPV1NPC1RAB9A
SCHEMBL185085 0.82 BDKRB1 (0.47) BDKRB1FAAHTRPV1NPC1RAB9A
SCHEMBL185841 0.81 BDKRB1 (0.46) BDKRB1FAAHTRPV1
SCHEMBL14865356 0.80 BDKRB1 (0.52) BDKRB1CTSLHDAC1HDAC6
SCHEMBL14856425 0.77 BDKRB1 (0.48) BDKRB1FAAHTRPV1NPC1RAB9A
SCHEMBL2806049 0.77 BDKRB1 (0.62) BDKRB1CTSLCTSBCTSSHDAC1
SCHEMBL758571 0.77 BDKRB1 (0.47) BDKRB1FAAHTRPV1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed